Cargando…

Inflammasomes and Type 1 Diabetes

Microbiota have been identified as an important modulator of susceptibility in the development of Type 1 diabetes in both animal models and humans. Collectively these studies highlight the association of the microbiota composition with genetic risk, islet autoantibody development and modulation of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pearson, James Alexander, Wong, F. Susan, Wen, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219953/ https://www.ncbi.nlm.nih.gov/pubmed/34177937 http://dx.doi.org/10.3389/fimmu.2021.686956

Ejemplares similares

Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell Functions
por: Pearson, James A., et al.
Publicado: (2019)

Role of the inflammasome in insulin resistance and type 2 diabetes mellitus
por: Lu, Shen, et al.
Publicado: (2023)

Editorial: Immunopathology of Type 1 Diabetes
por: Green, E. Allison, et al.
Publicado: (2022)

Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
por: Grant, Ryan W., et al.
Publicado: (2013)

Mitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine Model
por: Carlos, Daniela, et al.
Publicado: (2017)

Regulatory B Cells: Role in Type 1 Diabetes
por: Boldison, Joanne, et al.
Publicado: (2021)

IL-10 Deficiency Accelerates Type 1 Diabetes Development via Modulation of Innate and Adaptive Immune Cells and Gut Microbiota in BDC2.5 NOD Mice
por: Huang, Juan, et al.
Publicado: (2021)

Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness
por: Dyer, Adam H., et al.
Publicado: (2022)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Inflammasomes and Fibrosis
por: Zhang, Wen-Juan, et al.
Publicado: (2021)

Environmental Determinants of Type 1 Diabetes: From Association to Proving Causality
por: Quinn, Lauren M., et al.
Publicado: (2021)

The NLRP1 inflammasome in skin diseases
por: Burian, Marc, et al.
Publicado: (2023)

Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
por: Lee, Hye-Mi, et al.
Publicado: (2013)

Relevance of the Pyroptosis-Related Inflammasome Pathway in the Pathogenesis of Diabetic Kidney Disease
por: Liu, Pan, et al.
Publicado: (2021)

NLRP1 Inflammasomes: A Potential Target for the Treatment of Several Types of Brain Injury
por: Mi, Liang, et al.
Publicado: (2022)

Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
por: Kantono, Melvin, et al.
Publicado: (2017)

Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice
por: Chen, Dawei, et al.
Publicado: (2023)

IRAK-M Deficiency Promotes the Development of Type 1 Diabetes in NOD Mice
por: Tan, Qiyuan, et al.
Publicado: (2014)

The roles of inflammasomes in cancer
por: Deng, Zihan, et al.
Publicado: (2023)

The NLRP3 Inflammasome and Its Role in T1DM
por: Sun, Xiaoxiao, et al.
Publicado: (2020)

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
por: Zheng, Xiaoqin, et al.
Publicado: (2023)

Inflammasomes in Alveolar Bone Loss
por: Li, Yang, et al.
Publicado: (2021)

Bacterial Exotoxins and the Inflammasome
por: Greaney, Allison J., et al.
Publicado: (2015)

Inflammasome Meets Centrosome: Understanding the Emerging Role of Centrosome in Controlling Inflammasome Activation
por: Wu, Dandan, et al.
Publicado: (2022)

Inflammasome/IL-1β Responses to Streptococcal Pathogens
por: LaRock, Christopher N., et al.
Publicado: (2015)

Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis
por: Jiang, Qi, et al.
Publicado: (2022)

Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling
por: Li, Yang, et al.
Publicado: (2023)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

The Human-Specific STING Agonist G10 Activates Type I Interferon and the NLRP3 Inflammasome in Porcine Cells
por: Ming, Sheng-Li, et al.
Publicado: (2020)

NLRP3 inflammasome as a sensor of micro- and nanoplastics immunotoxicity
por: Alijagic, Andi, et al.
Publicado: (2023)

Evaluation of Canonical Inflammasome Activation in Human Monocytes by Imaging Flow Cytometry
por: Lage, Silvia Lucena, et al.
Publicado: (2019)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

NLRP3 inflammasome-induced pyroptosis in digestive system tumors
por: Wen, Jiexia, et al.
Publicado: (2023)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018)

The Pyrin Inflammasome in Health and Disease
por: Schnappauf, Oskar, et al.
Publicado: (2019)

Inflammasomes in Inflammation-Induced Cancer
por: Lin, Chu, et al.
Publicado: (2017)

The Inflammasome in Times of COVID-19
por: de Rivero Vaccari, Juan Carlos, et al.
Publicado: (2020)

From Inflammasome to Exosome—Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?
por: Cypryk, Wojciech, et al.
Publicado: (2018)

Chemokines in Type 1 Diabetes Mellitus
por: Pan, Xiongfeng, et al.
Publicado: (2022)

Updating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer
por: Wen, Jiexia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5r7dtbcukvspd03kqomsd78dd